Fund Holdings — Sands Capital Alternatives, LLC

Total Portfolio Value:
$459.73M
Total Bought:
$111.10M
Total Sold:
$51.23M
Net Transaction:
+$59.87M
Notable People:
Sands Capital Management, Lp, Erin Elizabeth Soule
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Klaviyo, Inc.COM SER A(KVYO)3,515,3253,470,694-44,631$124.37M$143.13M31.13%+$18.76M
Nu Holdings Ltd.CL A(NU)5,498,8027,021,159+1,522,357$75.06M$72.74M15.82%-$2.32M
DoorDash, Inc.CL A(DASH)423,338407,343-15,995$60.42M$68.33M14.86%+$7.91M
Inhibikase Therapeutics, Inc.(IKT)010,950,000+10,950,000$0$35.59M7.74%+$35.59M
Coupang, Inc.CL A(CPNG)11,931924,712+912,781$292.9K$20.33M4.42%+$20.03M
UiPath, Inc.CL A(PATH)1,155,2461,584,677+429,431$14.79M$20.14M4.38%+$5.35M
Datadog, Inc.CL A(DDOG)1,40697,788+96,382$161.8K$13.97M3.04%+$13.81M
Acrivon Therapeutics Inc2,122,6052,122,6050$14.86M$12.78M2.78%-$2.08M
Monday Com LtdSHS
SHS
048,278+48,278$0$11.37M2.47%+$11.37M
Tarsus Pharmaceuticals, Inc.(TARS)170,000170,0000$5.59M$9.41M2.05%+$3.82M
Samsara Inc.CL A(IOT)3,172198,690+195,518$152.6K$8.68M1.89%+$8.53M
Toast, Inc.CL A(TOST)4,453231,530+227,077$126.1K$8.44M1.84%+$8.31M
10x Genomics, Inc.CL A(TXG)481,770481,7700$10.88M$6.92M1.50%-$3.96M
Snowflake Inc.CL A(SNOW)108,30439,007-69,297$12.44M$6.02M1.31%-$6.42M
Acumen Pharmaceuticals, Inc.(ABOS)3,417,0753,417,0750$8.47M$5.88M1.28%-$2.60M
CrowdStrike Holdings, Inc.CL A(CRWD)22117,100+16,879$62.0K$5.85M1.27%+$5.79M
BioAge Labs, Inc.(BIOA)1,086,353786,353-300,000$22.60M$4.55M0.99%-$18.04M
Candel Therapeutics, Inc.(CADL)405,837405,8370$2.81M$3.52M0.77%+$710.2K
Taysha Gene Therapies, Inc.(TSHA)724,873724,8730$1.46M$1.25M0.27%-$203.0K
908 Devices Inc.(MASS)237,258237,2580$823.3K$522.0K0.11%-$301.3K
Spruce Biosciences Inc787,007715,817-71,190$369.9K$300.6K0.07%-$69.3K
GitLab Inc.CL A(GTLB)6580-658$33.9K$0—-$33.9K
Page 1 of 1
Sands Capital Alternatives, LLC — 13F Holdings — Q4 2024 | TickerTrail